Smith Group Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-6,140
| Closed | -$152K | – | 505 |
|
|
2016
Q2 | $152K | Buy |
6,140
+2,512
| +69% | +$62.2K | ﹤0.01% | 288 |
|
|
2016
Q1 | $105K | Buy |
3,628
+867
| +31% | +$25.1K | ﹤0.01% | 269 |
|
|
2015
Q4 | $102K | Buy |
2,761
+288
| +12% | +$10.6K | ﹤0.01% | 292 |
|
|
2015
Q3 | $120K | Buy |
2,473
+68
| +3% | +$3.3K | ﹤0.01% | 244 |
|
|
2015
Q2 | $166K | Buy |
+2,405
| New | +$166K | 0.01% | 227 |
|